Carney, Greg <br/><br/>
Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study.  [electronic resource] 

 -  Addiction (Abingdon, England)  08 2020 
 - 1534-1546 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1360-0443 
<br/><br/><label>Standard No.: </label>10.1111/add.14951  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Bupropion--adverse effects<br/>Cardiovascular Diseases--epidemiology<br/>Cohort Studies<br/>Female<br/>Humans<br/>Male<br/>Mental Disorders--epidemiology<br/>Middle Aged<br/>Nicotinic Agonists--adverse effects<br/>Retrospective Studies<br/>Smoking Cessation--methods<br/>Smoking Cessation Agents--adverse effects<br/>Tobacco Use Cessation Devices--adverse effects<br/>Tobacco Use Disorder--drug therapy<br/>United States--epidemiology<br/>Varenicline--adverse effects<br/>Young Adult